Pre-order Enquiry
Request Free Sample
Global Neurostimulation Devices Market Growth 2019-2024
SKU ID : LPI-13842500 | Publishing Date : 12-Feb-2019 | No. of pages : 139
Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.
The global average price of implantable neurostimulation devices is in the fluctuating trend, 22.10 K USD/Unit in 2012 to 21.24 K USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of implantable neurostimulation devices includes spinal cord stimulation (SCS), gastric electric stimulation (GES), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS) and other type, and the proportion of spinal cord stimulation (SCS) in 2016 is about 57%, and the proportion is in increasing trend from 2012 to 2016.
Implantable neurostimulation devices are widely used to treat pain management, parkinson’s disease, urinary and fecal incontinence, epilepsy, gastroparesis and other field. The most proportion of implantable neurostimulation devices is used for pain management, and the consumption proportion in 2016 is about 55%.
North America region is the largest supplier of implantable neurostimulation devices, with a production market share nearly 82% in 2016. Europe is the second largest supplier of implantable neurostimulation devices, enjoying production market share nearly 12% in 2016.
North America is the largest consumption place, with a consumption market share nearly 42% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Neurostimulation Devices market will register a 11.2% CAGR in terms of revenue, the global market size will reach US$ 8120 million by 2024, from US$ 4290 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Neurostimulation Devices business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurostimulation Devices market by product type, application, key manufacturers and key regions and countries.
This study considers the Neurostimulation Devices value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Pain Management
Parkinson’s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Medtronic
Boston Scientific
St. Jude Medical (Abbott)
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Neurostimulation Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Neurostimulation Devices market by identifying its various subsegments.
Focuses on the key global Neurostimulation Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Neurostimulation Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Neurostimulation Devices submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The global average price of implantable neurostimulation devices is in the fluctuating trend, 22.10 K USD/Unit in 2012 to 21.24 K USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of implantable neurostimulation devices includes spinal cord stimulation (SCS), gastric electric stimulation (GES), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS) and other type, and the proportion of spinal cord stimulation (SCS) in 2016 is about 57%, and the proportion is in increasing trend from 2012 to 2016.
Implantable neurostimulation devices are widely used to treat pain management, parkinson’s disease, urinary and fecal incontinence, epilepsy, gastroparesis and other field. The most proportion of implantable neurostimulation devices is used for pain management, and the consumption proportion in 2016 is about 55%.
North America region is the largest supplier of implantable neurostimulation devices, with a production market share nearly 82% in 2016. Europe is the second largest supplier of implantable neurostimulation devices, enjoying production market share nearly 12% in 2016.
North America is the largest consumption place, with a consumption market share nearly 42% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Neurostimulation Devices market will register a 11.2% CAGR in terms of revenue, the global market size will reach US$ 8120 million by 2024, from US$ 4290 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Neurostimulation Devices business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurostimulation Devices market by product type, application, key manufacturers and key regions and countries.
This study considers the Neurostimulation Devices value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Pain Management
Parkinson’s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Medtronic
Boston Scientific
St. Jude Medical (Abbott)
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Neurostimulation Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Neurostimulation Devices market by identifying its various subsegments.
Focuses on the key global Neurostimulation Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Neurostimulation Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Neurostimulation Devices submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
